| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Madhavan P Nair, Gloria Figueroa, Gianna Casteleiro, Karla Muñoz, Marisela Agudel. Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials. Journal of alcoholism and drug dependence. vol 3. issue 1. 2020-10-01. PMID:26478902. |
due to the legalization of marijuana and the increased demand for cannabis and alcohol consumption, research efforts highlighting the biomedical consequences of the use of alcohol and cannabinoids are not only relevant to the substance abuse scientific field, but are also of public health interest. |
2020-10-01 |
2023-08-13 |
human |
| Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, Nicolas Flaman. Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs. Frontiers in pharmacology. vol 7. 2020-10-01. PMID:27695418. |
impact of cannabis, cannabinoids, and endocannabinoids in the lungs. |
2020-10-01 |
2023-08-13 |
human |
| Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, Nicolas Flaman. Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs. Frontiers in pharmacology. vol 7. 2020-10-01. PMID:27695418. |
although the cannabinoid system is present and crucial in many human tissues, studying the impact of cannabinoids on the lungs is particularly relevant because of their contact with exogenous cannabinoids in the context of marijuana consumption. |
2020-10-01 |
2023-08-13 |
human |
| Sebastian Walther, Michael Halper. Cannabinoids and Dementia: A Review of Clinical and Preclinical Data. Pharmaceuticals (Basel, Switzerland). vol 3. issue 8. 2020-10-01. PMID:27713372. |
while preclinical findings suggest causal treatment strategies involving cannabinoids, clinical trials have only assessed the suitability of cannabinoid receptor agonists, antagonists and cannabidiol for the symptomatic treatment of dementia. |
2020-10-01 |
2023-08-13 |
human |
| Robin M Murray, Harriet Quigley, Diego Quattrone, Amir Englund, Marta Di Fort. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 15. issue 3. 2020-10-01. PMID:27717258. |
traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. |
2020-10-01 |
2023-08-13 |
human |
| Robin M Murray, Harriet Quigley, Diego Quattrone, Amir Englund, Marta Di Fort. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 15. issue 3. 2020-10-01. PMID:27717258. |
high-potency cannabis and synthetic cannabinoids carry the greatest risk. |
2020-10-01 |
2023-08-13 |
human |
| Robin M Murray, Harriet Quigley, Diego Quattrone, Amir Englund, Marta Di Fort. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 15. issue 3. 2020-10-01. PMID:27717258. |
irrespective of whether use of cannabis is decriminalized or legalized, the evidence that it is a component cause of psychosis is now sufficient for public health messages outlining the risk, especially of regular use of high-potency cannabis and synthetic cannabinoids. |
2020-10-01 |
2023-08-13 |
human |
| Rabia Bilic. Synthetic cannabinoids. Northern clinics of Istanbul. vol 1. issue 2. 2020-10-01. PMID:28058316. |
primary psychoactive ingredient of cannabis is Δ 9-tetrahydrocannabinoid which is partial agonist of cannabinoid receptors, while synthetic cannabinoids are potent, and complete agonists of these receptors. |
2020-10-01 |
2023-08-13 |
Not clear |
| E Joseph Brand, Zhongzhen Zha. Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids? Frontiers in pharmacology. vol 8. 2020-10-01. PMID:28344554. |
cannabis in chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids? |
2020-10-01 |
2023-08-13 |
Not clear |
| Timothy W Lefever, Julie A Marusich, Brian F Thomas, Daniel G Barrus, Nicholas C Peiper, Richard C Kevin, Jenny L Wile. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice. Substance abuse : research and treatment. vol 11. 2020-10-01. PMID:28469427. |
smoking is the most common route of administration for cannabis; however, vaping cannabis extracts and synthetic cannabinoids ("fake marijuana") in electronic cigarette devices has become increasingly popular. |
2020-10-01 |
2023-08-13 |
mouse |
| George Pitsilis, Dimitrios Spyridakos, George G Nomikos, George Panagi. Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ Frontiers in pharmacology. vol 8. 2020-10-01. PMID:28487656. |
adolescent female cannabinoid exposure diminishes the reward-facilitating effects of Δ marijuana is currently the most commonly abused illicit drug. |
2020-10-01 |
2023-08-13 |
rat |
| Ahmet Bulent Yazici, Esra Yazici, Atila Ero. Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid Withdrawal. Case reports in medicine. vol 2017. 2020-10-01. PMID:28487743. |
effects of scs on the central nervous system are similar to other cannabinoids, but 2-100 times more potent than marijuana. |
2020-10-01 |
2023-08-13 |
Not clear |
| Michael Karass, Savneek Chugh, Gabriela Andries, Aleksandra Mamorska-Dyga, John C Nelson, Praveen N Chande. Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists. Stem cell investigation. vol 4. 2020-10-01. PMID:28607917. |
as marijuana is illegal in the majority of countries, the use of readily available and unregulated synthetic cannabinoids (scbs) has increased. |
2020-10-01 |
2023-08-13 |
Not clear |
| Aviv M Weinstein, Paola Rosca, Liana Fattore, Edythe D Londo. Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Frontiers in psychiatry. vol 8. 2020-10-01. PMID:28878698. |
synthetic cannabinoid products have effects that are somewhat similar to those of natural cannabis but more potent and long-lasting than thc. |
2020-10-01 |
2023-08-13 |
Not clear |
| Stacey S Cofield, Amber Salter, Tuula Tyry, Christina Crowe, Gary R Cutter, Robert J Fox, Ruth Ann Marri. Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants. Neurology. Clinical practice. vol 7. issue 4. 2020-10-01. PMID:29185555. |
few large studies have been conducted about the perceptions and current usage of marijuana and medical cannabinoids in persons with ms. |
2020-10-01 |
2023-08-13 |
human |
| Amitoj Singh, Sajeev Saluja, Akshat Kumar, Sahil Agrawal, Munveer Thind, Sudip Nanda, Jamshid Shiran. Cardiovascular Complications of Marijuana and Related Substances: A Review. Cardiology and therapy. vol 7. issue 1. 2020-10-01. PMID:29218644. |
commonly, the traditional cannabis has been replaced by potent synthetic cannabinoids and cannabimimetics in various forms. |
2020-10-01 |
2023-08-13 |
Not clear |
| Tara M Lovestead, Thomas J Brun. Determination of Cannabinoid Vapor Pressures to Aid in Vapor Phase Detection of Intoxication. Forensic chemistry (Amsterdam, Netherlands). vol 5. 2020-10-01. PMID:29266138. |
the vapor pressures of two important cannabinoids, cannabidiol (cbd) and Δ |
2020-10-01 |
2023-08-13 |
Not clear |
| Lucas M Bryant, Kelly E Daniels, David M Cognetti, Patrick Tassone, Adam J Luginbuhl, Joseph M Curr. Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients. Laryngoscope investigative otolaryngology. vol 3. issue 3. 2020-10-01. PMID:30062131. |
therapeutic cannabis and endocannabinoid signaling system modulator use in otolaryngology patients. |
2020-10-01 |
2023-08-13 |
Not clear |
| Lucas M Bryant, Kelly E Daniels, David M Cognetti, Patrick Tassone, Adam J Luginbuhl, Joseph M Curr. Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients. Laryngoscope investigative otolaryngology. vol 3. issue 3. 2020-10-01. PMID:30062131. |
1) review benefits and risks of cannabis use, with emphasis on otolaryngic disease processes; 2) define and review the endocannabinoid signaling system (ess); and 3) review state and federal regulations for the use and research of cannabis and ess modulators. |
2020-10-01 |
2023-08-13 |
Not clear |
| Raihan Faroqui, Peter Mena, Allen R Wolfe, Joseph Bibawy, George A Visvikis, Michael T Mantell. Acute carotid thrombosis and ischemic stroke following overdose of the synthetic cannabinoid K2 in a previously healthy young adult male. Radiology case reports. vol 13. issue 3. 2020-10-01. PMID:30167028. |
the patient endorsed smoking k2-a synthetic cannabinoid (sc) with structural similarity to cannabis. |
2020-10-01 |
2023-08-13 |
Not clear |